One-pot synthesis and characterization of a BSA-Cu2S/CuS quantum dots drug delivery system based on biuret’s
Fecha
2025-01-22Autor
Hernandez Paz, Juan Francisco
Rodriguez Gonzalez, Claudia
Martel-Estrada, Santos-Adriana
Valencia Gomez, Laura Elizabeth
Camacho Montes, Hector
Olivas Armendariz, Imelda
Estrada Rojas, Porfirio
Mendoza Duarte, Mónica-Elvira
Metadatos
Mostrar el registro completo del ítemResumen
Research on chalcogenide-based quantum dots(QDs) has advanced significantly over recent decades,
largely due to their excellent optical properties, particularly photoluminescence, and relatively low
toxicity. Among these, Cu2S and CuS quantum dots have demonstrated notable photothermal effects
and antibacterial activity, making them promising candidates for various biomedical applications,
including cancer treatment. This study focuses on the synthesis of CuS and Cu2S quantum dots
functionalized with bovine serum albumin (BSA), marking an important step toward their potential
biomedical use. The functionalization was achieved through a one-pot synthesis method,
characterized by its ability to offer higher chemical yield, elimination of toxic solvents, and provide a
method that is simple, economical, and well-controlled. This synthesis produced four samples with
varying BSA concentrations. Due to the lower protein concentration, which provides fewer nucleation
sites, sample A(BSA concentration 5 mg ml−1
)showed a particle size distribution over 100 nm and
low stability over time. Sample B (25 mg ml−1 BSA) and C(50 mg ml−1 BSA)showed excellent stability
and particle sizes within the expected range for Cu2S and CuS quantum dots(<2.4 nm). Sample D was
synthesized with lower BSA concentration (2.5 mg ml−1
) and was used only for comparison in few
analyses. Fourier-transform infrared (FTIR)spectroscopy confirmed the structural integrity of BSA
after functionalization, while x-ray diffraction (XRD) analysis verified the formation of CuS and Cu2S
crystals. Additional tests, including fluorescence and UV–vis spectroscopy, validated the optical
properties of the quantum dots. Transmission electron microscopy (TEM) confirmed crystalline
structure of the CuS and Cu2S quantum dots, with particle size measurements aligning with
expectations. Finally, MTT assays confirmed that the synthesized quantum dots are non-toxic, further
supporting their potential for biomedical applications.
